NCT00833196 Factors Influencing Response to One BoNT-A Injection Cycle in Subjects Suffering From Idiopathic Cervical Dystonia Status COMPLETED Phase N/A
NCT00824512 Efficacy of EGb761 in Patients Suffering From Friedreich Ataxia Status COMPLETED Phase PHASE2
NCT00814346 Effect of EGb761® on Brain Glucose Metabolism in Three Groups of Elderly Defined by Cognitive Functions Status COMPLETED Phase PHASE2
NCT00774930 An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome Status COMPLETED Phase PHASE3
NCT00747786 Non Interventional Post Marketing Programme in Neuroendocrine Tumours Status COMPLETED Phase N/A
NCT00747604 IGFD Registry: A Patient Registry for Monitoring Long-term Safety and Efficacy of Increlex Status TERMINATED Phase N/A
NCT00735852 Decapeptyl SR With Livial Add Back Therapy in the Management of Chronic Cyclical Pelvic Pain in Pre Menopausal Women Status COMPLETED Phase PHASE4
NCT00729313 Efficacy and Safety of Lanreotide Versus Placebo for Treatment of Patients With Digestive Fistulae Status COMPLETED Phase PHASE3
NCT00710307 Epidemiology Study on Insulin-like Growth Factor-1 in Children With Idiopathic Short Stature (EPIGROW Study) Status COMPLETED Phase N/A
NCT00701363 Study to Assess the Efficacy of an Extended Injection Interval Schedule of Lanreotide Autogel in Acromegalic Subjects Status COMPLETED Phase PHASE4
NCT00690898 Lanreotide as Primary Treatment for Acromegalic Patients With Pituitary Gland Macroadenoma Status COMPLETED Phase PHASE3
NCT00686348 Somatuline® Depot (Lanreotide) for Acromegaly Post-Marketing Observational Study Status COMPLETED Phase N/A
NCT00667069 Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer Status COMPLETED Phase PHASE3
NCT00630695 Prevention of Lymphorrhea by Lanreotide in Axillary Dissection for Breast Cancer Status COMPLETED Phase PHASE3
NCT00578097 Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder Status TERMINATED Phase PHASE2
NCT00572156 rhGH and rhIGF-1 Combination Therapy in Children With Short Stature Associated With IGF-1 Deficiency Status TERMINATED Phase PHASE2